toxoplasmosis: A parasitic disease contracted by the ingestion or fetal transmission of toxoplasma gondii.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpoints |
1089 |
6. Filter based on genotype QC (FinnGen only) |
1046 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Protozoal diseases
based on the number of shared cases.
Similar with more cases:
- Certain infectious and parasitic diseases
- Certain infectious and parasitic diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 6426 | 2933 | 3386 |
| Only index persons | 5431 | 2564 | 2867 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.09 | 0.08 | 0.09 |
| Only index persons | 0.10 | 0.09 | 0.11 |
| Median age at first event (years) | |||
| Whole population | 46.07 | 44.91 | 47.33 |
| Only index persons | 44.50 | 43.08 | 45.77 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1046 | 525 | 521 |
| Unadjusted period prevalence (%) | 0.21 | 0.19 | 0.24 |
| Median age at first event (years) | 59.18 | 54.63 | 63.76 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1089
- Matched controls
- 10890
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
TGC00
NOMESCO Finland
Bronchial lavation
35.2
307.7
307
120
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
+∞
307.7
564
*
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
14.4
279.1
285
262
UGC12
NOMESCO Finland
Flexible bronchoscopy
11.0
274.1
354
456
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
12.9
227.4
244
239
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
10.8
219.2
271
324
R50.9
ICD-10 Finland
Fever, unspecified
6.0
171.3
412
997
J18.9
ICD-10 Finland
Pneumonia, unspecified
5.3
165.4
554
1773
ZX108
NOMESCO Finland
Inhalation
35.8
154.5
98
30
XW000
NOMESCO Finland
Bone marrow biopsy
9.4
140.0
182
227
B59
ICD-10 Finland
Pneumocystosis
+∞
126.6
119
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
5.5
124.4
297
695
L03AA02
ATC
filgrastim; parenteral
10.7
119.7
138
146
WW500
NOMESCO Finland
Blood transfusion
8.4
111.6
157
214
ZX120
NOMESCO Finland
Intravenous
5.4
106.1
248
564
JN4AD
NOMESCO Finland
Body CT examination
5.0
105.9
275
684
GD1AD
NOMESCO Finland
Thorax CT examination
6.5
104.7
190
341
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
12.5
103.1
105
92
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
4.9
95.2
254
642
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.8
94.6
744
3936
H02AB06
ATC
prednisolone; systemic
3.6
90.0
727
3866
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
15.9
83.4
73
49
L04AA06
ATC
mycophenolic acid; systemic
11.6
82.8
88
82
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
6.7
82.4
142
240
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
6.3
82.2
151
272
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
9.2
80.6
102
121
JN4BD
NOMESCO Finland
Extensive body CT
4.3
78.4
247
703
D70.82
ICD-10 Finland
Drug-induced neutropenia
12.7
78.0
78
66
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
13.2
74.1
72
58
127
Kela drug reimbursment
Transplant complication
12.1
74.0
76
67
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
4.7
72.8
190
466
M04AA01
ATC
allopurinol; systemic
3.8
70.5
264
845
A04AA01
ATC
ondansetron; systemic, rectal
4.6
70.3
191
483
H32.0*B58.0
ICD-10 Finland
Toxoplasma chorioretinitis
+∞
68.5
65
*
J01MA14
ATC
moxifloxacin; systemic
4.3
67.9
200
538
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
7.4
67.6
103
152
H02AB02
ATC
dexamethasone; systemic
3.9
66.5
238
736
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
15.7
66.1
58
39
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
6.2
66.0
120
213
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
10.1
65.5
76
80
J01FF01
ATC
clindamycin; systemic
3.0
65.1
439
1997
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
11.8
64.5
67
60
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.3
64.4
313
1178
L03AA13
ATC
pegfilgrastim; parenteral
5.7
62.7
125
242
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
6.8
60.3
99
158
L04AX01
ATC
azathioprine; systemic
6.0
59.3
111
202
Z51.5
ICD-10 Finland
Palliative care
4.3
59.1
172
456
A03FA01
ATC
metoclopramide; systemic, rectal
3.0
58.6
363
1560
D70.89
ICD-10 Finland
Neutropenic splenomegaly
13.7
58.3
55
42
B50.9
ICD-10 Finland
Plasmodium falciparum malaria, unspecified
+∞
56.8
54
*
B54
ICD-10 Finland
Unspecified malaria
+∞
55.7
53
*
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
4.6
55.1
145
355
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
16.3
54.9
47
30
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.5
54.2
146
364
WW200
NOMESCO Finland
Immunization
7.3
53.6
81
118
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
4.0
53.3
173
495
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
20.2
53.1
41
21
J01MA12
ATC
levofloxacin; systemic
3.0
52.4
310
1289
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.6
51.8
481
2518
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
19.7
51.2
40
21
L04AD01
ATC
ciclosporin; systemic
9.1
50.4
63
73
C03CA01
ATC
furosemide; systemic
2.6
48.8
428
2165
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.2
47.7
233
864
JN6AD
NOMESCO Finland
CT of torso and neck
9.4
47.6
58
65
J05AB11
ATC
valaciclovir; oral
3.1
47.2
245
941
TPX10
NOMESCO Finland
Implantation of vascular injection port
6.0
46.9
86
153
TK800
NOMESCO Finland
Hemodialysis
7.3
44.9
68
99
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
13.6
44.4
42
32
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.4
43.9
183
615
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
10.4
43.6
49
49
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
3.3
43.6
193
673
A04AA02
ATC
granisetron; systemic, transdermal
3.8
41.0
134
383
L03AA14
ATC
lipegfilgrastim; parenteral
7.4
38.4
57
81
H02AB07
ATC
prednisone; oral
2.9
38.0
217
870
TPH04
NOMESCO Finland
Cathetrisation of vein
2.5
37.8
324
1589
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
9.7
37.3
44
47
1XC02, ,
NOMESCO Finland
12.9
35.9
35
28
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
5.6
35.5
70
133
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.9
35.0
110
305
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
7.2
34.6
52
75
N02AA05
ATC
oxycodone; systemic
2.5
34.5
265
1229
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
6.7
34.4
56
88
L04AA01
ATC
[U] ciclosporin
9.3
34.4
42
47
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
8.9
34.2
43
50
A41.9
ICD-10 Finland
Sepsis, unspecified
4.8
34.1
80
177
ZX112
NOMESCO Finland
Subcutaneous
5.9
33.3
61
108
A07AA09
ATC
vancomycin; oral
9.0
33.0
41
47
WZC00
NOMESCO Finland
Treatment plan or consultation
2.1
31.3
454
2732
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
9.0
31.2
39
45
L04AD02
ATC
tacrolimus; systemic
9.3
30.5
37
41
Z94.0
ICD-10 Finland
Kidney transplant status
9.3
30.5
37
41
B58.9
ICD-10 Finland
Toxoplasmosis, unspecified
+∞
30.3
29
*
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
5.9
30.1
55
97
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.4
30.1
247
1173
A02BC02
ATC
pantoprazole; systemic
2.2
29.6
801
6043
H02AB09
ATC
hydrocortisone; systemic
5.7
29.4
56
103
13000
ICD-8 Finland
Toxoplasmosis, Acquired
+∞
29.3
28
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
4.5
28.9
72
167
WX892
NOMESCO Finland
Monitored bed care
3.1
28.4
130
457
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
10.3
28.4
32
32
C90.0
ICD-10 Finland
Multiple myeloma
8.3
27.9
37
46
Z49.1
ICD-10 Finland
Extracorporeal dialysis
7.6
27.3
39
53
L04AX03
ATC
methotrexate; systemic
2.8
27.3
150
584
B03XA01
ATC
erythropoietin; parenteral
9.7
27.2
32
34
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.8
26.8
144
553
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.1
26.8
372
2176
B58.0
ICD-10 Finland
Toxoplasma oculopathy
+∞
26.1
25
*
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
3.5
26.0
94
286
B03XA02
ATC
darbepoetin alfa; parenteral
5.3
25.9
53
104
R06.0
ICD-10 Finland
Dyspnoea
2.1
25.6
348
2013
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
6.1
25.4
45
77
1CX01, ,
NOMESCO Finland
39.9
25.0
31
8
Z3231
NOMESCO Finland
Registered nurse
2.0
24.5
350
2055
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
7.8
24.3
34
45
D64.9
ICD-10 Finland
Anaemia, unspecified
2.6
24.3
152
631
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
3.1
24.3
106
362
N17.9
ICD-10 Finland
Acute renal failure, unspecified
3.9
24.1
74
201
J17.3
ICD-10 Finland
Pneumonia in parasitic diseases
+∞
24.0
23
*
A07EC01
ATC
sulfasalazine; oral, rectal
2.9
23.9
119
438
L01BA01
ATC
methotrexate; systemic
4.2
23.8
65
162
A11CC03
ATC
alfacalcidol; systemic
5.1
23.7
50
101
B01AB10
ATC
tinzaparin; parenteral
2.6
23.7
153
645
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
8.0
23.5
32
41
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
9.9
23.3
27
28
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
4.2
23.0
62
153
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
3.3
22.9
91
293
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
3.3
22.9
90
288
P01BA02
ATC
hydroxychloroquine; oral
2.8
22.7
121
462
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
6.7
22.7
36
55
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.5
22.5
160
705
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.6
22.3
140
581
WW300
NOMESCO Finland
Transfer of autologic stem cells
21.9
22.2
32
15
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.2
22.2
91
299
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.7
21.9
124
488
AA1BD
NOMESCO Finland
Extensive CT of head and brain
4.6
21.4
51
114
A12AA04
ATC
calcium carbonate; oral
5.8
21.3
39
69
H02AB04
ATC
methylprednisolone; systemic
2.3
21.2
192
940
R4110
NOMESCO Finland
Physiotherapy
1.9
21.1
347
2121
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
8.6
21.1
27
32
WF004
NOMESCO Finland
Palliative radiotherapy
5.2
21.1
44
88
J05AB01
ATC
aciclovir; systemic
2.0
21.0
268
1500
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
7.8
20.9
29
38
PJA10
NOMESCO Finland
Exploration of lymph nodes
6.3
20.7
35
57
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
6.3
20.7
35
57
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
4.5
20.5
50
114
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
4.4
20.4
52
123
Z2446
NOMESCO Finland
Social worker
2.9
20.2
104
389
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
4.2
20.2
55
137
A05AA02
ATC
ursodeoxycholic acid; oral
5.9
19.9
36
63
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
25.1
19.6
27
11
6BA02, ,
NOMESCO Finland
40.9
19.6
24
6
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
3.7
19.5
64
182
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
31.9
19.3
25
8
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.8
19.3
588
4315
ZXE00
NOMESCO Finland
One hour or less
1.8
19.3
454
3088
TPH07
NOMESCO Finland
Cathetrisation of artery
2.3
19.3
159
747
N18.0
ICD-10 Finland
End-stage renal disease
7.3
19.1
28
39
C83.1
ICD-10 Finland
Mantle cell lymphoma
23.0
19.1
27
12
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.1
18.9
209
1104
M05BX04
ATC
denosumab; parenteral
3.0
18.9
89
317
1302A
ICD-9 Finland
Toxoplasmosis, Chorioretinitis due to toxoplasmosis
+∞
18.8
18
*
13099
ICD-8 Finland
Toxoplasmosis, Unspecified
+∞
18.8
18
*
R81
ICPC
Pneumonia
3.7
18.7
60
168
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.0
18.7
240
1339
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
4.3
18.5
48
115
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.4
18.4
139
628
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
44.8
18.3
22
5
J01MA02
ATC
ciprofloxacin; systemic
1.8
18.2
446
3054
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.0
18.2
235
1313
ZXE10
NOMESCO Finland
More than one and less than three hours
1.8
18.1
425
2875
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.8
18.0
92
343
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.8
17.8
477
3348
B48.5
ICD-10 Finland
Pneumocystosis
+∞
17.8
17
*
H32.0
ICD-10 Finland
Chorioretinal inflammation in infectious and parasitic diseases classified elsewhere
+∞
17.8
17
*
A07AA02
ATC
nystatin; oral
2.9
17.7
86
312
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.9
17.6
88
324
J02AC03
ATC
voriconazole; systemic
24.5
17.4
24
10
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.9
17.3
83
299
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.8
17.2
89
334
JN3AD
NOMESCO Finland
Abdominal CT examination
2.2
17.2
152
734
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
2.8
17.0
90
341
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
5.1
17.0
36
73
L04AA13
ATC
[U] leflunomide
4.3
16.9
44
106
J96.0
ICD-10 Finland
Acute respiratory failure
5.6
16.7
32
59
H30.0
ICD-10 Finland
Focal chorioretinal inflammation
+∞
16.7
16
*
0840A
ICD-9 Finland
Malaria, Falciparum malaria [malignant tertian]
+∞
16.7
16
*
L01CA04
ATC
vinorelbine; systemic
7.1
16.6
25
36
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
7.1
16.6
25
36
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
18.2
16.5
25
14
N18.8
ICD-10 Finland
Other chronic renal failure
4.4
16.5
41
95
212
Kela drug reimbursment
Gout
4.9
16.5
36
75
WX720
NOMESCO Finland
Own respiration
3.0
16.4
75
263
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
4.0
16.3
47
122
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
5.5
16.0
31
58
Z3226
NOMESCO Finland
Physiotherapist
1.9
15.9
224
1283
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
2.6
15.9
95
384
N05CF01
ATC
zopiclone; oral
1.8
15.7
356
2361
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
13.2
15.7
27
21
XX3DW
NOMESCO Finland
Time consuming IT work
2.2
15.7
145
712
A46
ICD-10 Finland
Erysipelas
2.0
15.6
179
954
Z2221
NOMESCO Finland
Medical doctor
1.8
15.6
317
2037
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
5.7
15.6
29
52
B02.9
ICD-10 Finland
Zoster without complication
2.6
15.3
92
372
B99
ICD-10 Finland
Other and unspecified infectious diseases
4.4
15.3
38
88
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
4.4
15.1
38
89
NH3EA
NOMESCO Finland
Feet X-ray examination with load
4.5
14.8
36
82
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.8
14.8
290
1840
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
21.4
14.7
21
10
M01CB01
ATC
sodium aurothiomalate; parenteral
5.7
14.7
27
48
I50.9
ICD-10 Finland
Heart failure, unspecified
2.1
14.4
158
827
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.3
14.3
121
572
L01AA02
ATC
chlorambucil; oral
22.6
14.2
20
9
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
2.6
14.1
85
344
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
12.2
14.1
25
21
RD210, ,
NOMESCO Finland
5.0
14.1
30
61
B01AB05
ATC
enoxaparin; parenteral
1.7
14.0
359
2449
WZC30
NOMESCO Finland
Teaching
1.9
13.8
188
1062
390
Kela drug reimbursment
Ibrutinib
34.5
13.5
17
5
Z3229
NOMESCO Finland
Other healthcare associate professional
2.3
13.5
105
479
J01DB01
ATC
cefalexin; oral
1.8
13.5
891
7726
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
13.0
13.4
23
18
WW409
NOMESCO Finland
Other aferesis
21.5
13.4
19
9
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
3.1
13.3
56
187
A04AA55
ATC
palonosetron, combinations; systemic
3.1
13.3
55
182
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
2.9
13.2
61
215
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
3.9
13.1
38
99
WX002
NOMESCO Finland
Sedation and analgesia
1.8
13.1
231
1413
SPAT1255
SPAT
Intravenous administration of medicine
2.5
13.1
88
376
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
3.4
13.0
47
143
WX726
NOMESCO Finland
High-flow oxygen therapy
28.7
13.0
17
6
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
12.9
252
1588
XF400
NOMESCO Finland
ECG with 12 standard connections
1.9
12.9
190
1100
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
3.4
12.8
46
139
XX1XW
NOMESCO Finland
Extensive written report from radiologist
4.0
12.8
36
92
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
12.8
297
1966
ZXD10
NOMESCO Finland
Scheduled procedure
1.6
12.7
417
3013
FB1AD
NOMESCO Finland
CT examination of arteria pulmonalis
3.9
12.7
37
97
AA1AD
NOMESCO Finland
CT of head and brain
1.7
12.7
309
2070
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.7
12.7
311
2088
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.2
12.6
51
166
7140A
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]
6.0
12.6
22
37
R05
ICD-10 Finland
Cough
1.8
12.4
234
1459
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.1
12.4
122
612
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.8
12.4
193
1136
TDM10
NOMESCO Finland
Puncture of maxillary antrum
3.0
12.2
55
191
R03AC02
ATC
salbutamol; inhalant
1.6
12.2
581
4572
A03
ICPC
Fever
1.9
12.2
179
1034
E87.5
ICD-10 Finland
Hyperkalaemia
4.6
12.2
29
65
B34.9
ICD-10 Finland
Viral infection, unspecified
3.5
12.2
41
119
137
Kela drug reimbursment
Uraemia requiring dialysis
6.1
12.2
21
35
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
2.7
12.1
66
254
L01AA01
ATC
cyclophosphamide; systemic
12.6
12.1
21
17
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
12.6
12.1
21
17
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
3.3
12.0
45
140
WX882
NOMESCO Finland
High dependency care
3.4
12.0
43
130
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
5.1
12.0
25
50
H30.9
ICD-10 Finland
Chorioretinal inflammation, unspecified
47.2
11.9
14
*
TAB00
NOMESCO Finland
Lumbar puncture
2.8
11.9
61
228
WX725
NOMESCO Finland
Noninvasive ventilation
2.5
11.8
73
300
C82.1
ICD-10 Finland
Follicular lymphoma grade II
9.8
11.8
23
24
WX110
NOMESCO Finland
Infiltration anesthesia
1.6
11.7
753
6326
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.6
11.7
478
3619
L01BB05
ATC
fludarabine; systemic
30.4
11.7
15
5
1512
Kela drug reimbursment
Ibrutinib
30.4
11.7
15
5
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
3.1
11.7
50
169
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
9.4
11.5
23
25
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.2
11.5
95
445
M05BA04
ATC
alendronic acid; oral
2.2
11.4
97
460
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
2.4
11.3
83
369
B23.1
ICD-10 Finland
HIV disease resulting in (persistent) generalized lymphadenopathy
9.7
11.3
22
23
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
4.8
11.2
25
53
N02AA01
ATC
morphine; systemic, rectal
4.1
11.2
30
74
J70.2
ICD-10 Finland
Acute drug-induced interstitial lung disorders
25.3
11.2
15
6
B23.8
ICD-10 Finland
HIV disease resulting in other specified conditions
25.3
11.2
15
6
3AC01, ,
NOMESCO Finland
8.2
11.1
24
30
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
5.3
11.1
22
42
329
Kela drug reimbursment
Lenalidomide
11.3
11.1
20
18
153
Kela drug reimbursment
Lenalidomid
8.7
11.1
23
27
R06AE07
ATC
cetirizine; oral
1.6
11.0
444
3338
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
4.9
11.0
24
50
B24
ICD-10 Finland
Unspecified human immunodeficiency virus [HIV] disease
14.1
11.0
18
13
WX302
NOMESCO Finland
Thoracal epidural anesthesy
2.5
11.0
70
292
YNB10
NOMESCO Finland
Collection of stem cells for transplant
43.8
10.9
13
*
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
4.2
10.9
29
71
J04BA02
ATC
dapsone; oral
12.1
10.9
19
16
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
15.7
10.8
17
11
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.9
10.8
140
774
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
4.0
10.8
30
76
RS221, ,
NOMESCO Finland
4.6
10.7
25
55
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
5.6
10.7
20
36
WX402
NOMESCO Finland
General anaesthesia
1.7
10.7
234
1515
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
60.6
10.6
12
*
L01XE27
ATC
[U] ibrutinib
60.6
10.6
12
*
UJF92
NOMESCO Finland
Capsular endoscopy
3.8
10.6
32
86
ZXA00
NOMESCO Finland
Right side
1.6
10.6
295
2032
J45.9
ICD-10 Finland
Asthma, unspecified
1.7
10.6
205
1284
R4190
NOMESCO Finland
Nutritional therapy
2.8
10.5
53
196
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
10.2
10.5
20
20
N12
ICD-10 Finland
Tubulo-interstitial nephritis, not specified as acute or chronic
4.5
10.5
25
56
L04AB01
ATC
etanercept; parenteral
4.7
10.5
24
52
B20.6
ICD-10 Finland
HIV disease resulting in Pneumocystis jirovecii pneumonia
111.1
10.4
11
*
ZXE20
NOMESCO Finland
More than three and less than five hours
1.8
10.4
162
950
B55.1
ICD-10 Finland
Cutaneous leishmaniasis
+∞
10.4
10
*
1309X
ICD-9 Finland
Toxoplasmosis, unspecified
+∞
10.4
10
*
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.4
10.4
74
325
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
2.3
10.4
84
390
UJF32
NOMESCO Finland
Coloscopy
1.6
10.3
284
1947
A10AC01
ATC
insulin (human); parenteral
2.2
10.3
92
444
N17.8
ICD-10 Finland
Other acute renal failure
5.0
10.3
22
45
C83.00
ICD-10 Finland
Lymphocytic lymphoma
23.6
10.3
14
6
N19
ICD-10 Finland
Unspecified kidney failure
2.9
10.2
49
177
E0000UV, ,
ATC
1.5
10.2
420
3160
L04AX04
ATC
lenalidomide; oral
8.0
10.1
22
28
ZX090
NOMESCO Finland
Other technic of radiotherapy
3.0
10.1
45
156
JN4CD
NOMESCO Finland
Very extensive body CT
2.7
10.1
53
201
A02BC01
ATC
omeprazole; systemic
1.6
10.0
287
1985
L04AB04
ATC
adalimumab; parenteral
3.6
10.0
32
90
C07AB07
ATC
bisoprolol; oral
1.5
9.9
521
4118
TQW99
NOMESCO Finland
Other minor procedure on skin
2.4
9.9
67
288
A04AD12
ATC
aprepitant; systemic
3.5
9.8
33
96
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.5
9.8
62
258
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.0
9.7
104
538
A10AB05
ATC
insulin aspart; parenteral
2.1
9.7
92
455
WW400
NOMESCO Finland
Plasmaferesis
55.5
9.7
11
*
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
5.4
9.7
19
36
J46
ICD-10 Finland
Status asthmaticus
3.4
9.6
34
102
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
1.7
9.6
194
1227
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
7.2
9.5
22
31
399
Kela drug reimbursment
Venetoclax
15.2
9.5
15
10
ZXD05
NOMESCO Finland
Urgent procedure
1.6
9.5
322
2314
ZXA05
NOMESCO Finland
Left side
1.6
9.4
263
1805
N02AX02
ATC
tramadol; systemic, rectal
1.5
9.4
459
3563
J17.1*B25.0
ICD-10 Finland
Cytomegaloviral pneumonitis
+∞
9.4
9
*
B51.9
ICD-10 Finland
Plasmodium vivax malaria without complication
+∞
9.4
9
*
08410
ICD-8 Finland
Vivax malaria (benign tertian)
+∞
9.4
9
*
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
5.2
9.4
19
37
K65.0
ICD-10 Finland
Acute peritonitis
5.2
9.4
19
37
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.3
9.4
68
301
M31.3
ICD-10 Finland
Wegener granulomatosis
12.5
9.4
16
13
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
4.1
9.3
25
62
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
13.8
9.2
15
11
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.6
9.2
52
205
H04.10
ICD-10 Finland
Dry eye syndrome
1.9
9.2
120
666
A06AD11
ATC
lactulose; oral
1.8
9.1
154
925
S01BA04
ATC
prednisolone; ophthalmic
3.3
9.1
33
101
N18.5
ICD-10 Finland
Chronic kidney disease, stage 5
10.1
9.0
17
17
N03AX16
ATC
[U] pregabalin
1.6
9.0
246
1680
Z94.2
ICD-10 Finland
Lung transplant status
18.8
8.9
13
7
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
24.2
8.9
12
5
XG410
NOMESCO Finland
Flow-volume spirometry
2.6
8.9
52
208
KA1AE
NOMESCO Finland
Kidney ultrasound examination
3.1
8.9
36
118
ZX121
NOMESCO Finland
Central venous catheter
12.7
8.9
15
12
HA1AA
NOMESCO Finland
X-ray mammography
2.1
8.7
83
411
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
3.9
8.7
25
65
D69.5
ICD-10 Finland
Secondary thrombocytopenia
14.2
8.7
14
10
1518, ,
Kela drug reimbursment
14.2
8.7
14
10
J12.8
ICD-10 Finland
Other viral pneumonia
6.7
8.7
21
32
L88
ICPC
Rheumatoid/seropositive arthritis
2.6
8.7
49
193
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
2.8
8.7
44
164
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
3.8
8.6
26
70
TND11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in joint, wrist or hand
4.4
8.6
21
48
XQ858
NOMESCO Finland
Oxygen partial pressure measurement
4.6
8.6
20
44
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
4.8
8.6
19
40
XF600
NOMESCO Finland
Bloodpressure measurement
2.2
8.6
76
366
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.7
8.6
191
1237
XQ855, ,
SPAT
7.0
8.6
20
29
L01XX52
ATC
venetoclax; oral
16.4
8.6
13
8
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
4.1
8.6
23
57
GDG10
NOMESCO Finland
Bilateral transplantation of lung
27.7
8.5
11
*
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.5
8.5
465
3672
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.7
8.4
45
172
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.9
8.4
105
574
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
12.9
8.4
14
11
S01CA02
ATC
prednisolone and antiinfectives; ophthalmic
4.7
8.4
19
41
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.4
8.4
58
252
B50.0
ICD-10 Finland
Plasmodium falciparum malaria with cerebral complications
+∞
8.3
8
*
08400
ICD-8 Finland
Falicparum malaria (malignant tertian)
+∞
8.3
8
*
B60.8
ICD-10 Finland
Other specified protozoal diseases
+∞
8.3
8
*
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
3.0
8.3
36
123
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
9.5
8.3
16
17
RS220, ,
NOMESCO Finland
4.1
8.3
22
54
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
3.2
8.3
32
102
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.5
8.3
53
222
R11
ICD-10 Finland
Nausea and vomiting
2.0
8.2
89
463
J01CA04
ATC
amoxicillin; systemic
1.5
8.2
846
7536
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
3.4
8.1
28
83
L01EL01
ATC
ibrutinib; oral
33.6
8.1
10
*
A02BC05
ATC
esomeprazole; systemic
1.5
8.1
415
3228
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
3.7
8.0
25
69
GDA11
NOMESCO Finland
Thoracoscopic biopsy of lung
10.1
8.0
15
15
N08.5*M31.3
ICD-10 Finland
Glomerular disorders in Wegener's granulomatosis
22.2
8.0
11
5
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.6
7.9
215
1462
J96.1
ICD-10 Finland
Chronic respiratory failure
3.2
7.9
31
100
V03AE02
ATC
sevelamer; oral
9.5
7.8
15
16
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
2.4
7.8
54
235
A06AH03
ATC
naloxegol; oral
3.7
7.8
24
66
C82.2
ICD-10 Finland
Follicular lymphoma grade III, unspecified
15.1
7.7
12
8
L04AX05
ATC
pirfenidone; oral
15.1
7.7
12
8
J01FA06
ATC
roxithromycin; oral
1.5
7.7
399
3100
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
2.4
7.7
50
211
R03BB04
ATC
tiotropium bromide; inhalant
1.8
7.7
114
658
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
4.6
7.7
18
40
J01AA02
ATC
doxycycline; systemic
1.5
7.6
803
7108
V03AE01
ATC
polystyrene sulfonate; oral
4.0
7.6
21
53
R28
ICPC
Limited function/disability (R)
4.0
7.6
21
53
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
25.2
7.6
10
*
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
3.2
7.6
29
92
R03AK08
ATC
formoterol and beclometasone; inhalant
2.4
7.5
51
220
J02AC01
ATC
fluconazole; systemic
1.5
7.4
363
2785
H26.3
ICD-10 Finland
Drug-induced cataract
6.5
7.4
18
28
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
3.3
7.4
27
83
A07EA06
ATC
budesonide; oral, local oral
2.6
7.4
43
172
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.6
7.4
196
1323
13020
ICD-8 Finland
Toxoplasmosis, Late effects of intra-utrine infection
+∞
7.3
7
*
0846X
ICD-9 Finland
Malaria, unspecified
+∞
7.3
7
*
1363A
ICD-9 Finland
Other and unspecified infectious and parasitic diseases, Pneumocystosis
+∞
7.3
7
*
J12.1
ICD-10 Finland
Respiratory syncytial virus pneumonia
6.3
7.3
18
29
R03BA08
ATC
ciclesonide; inhalant
1.9
7.2
90
491
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
2.6
7.2
41
163
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
2.4
7.2
49
212
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
2.2
7.1
57
264
P01AB01
ATC
metronidazole; oral, rectal
1.4
7.1
394
3090
FM1FN
NOMESCO Finland
Heart function isotope examination
10.1
7.0
13
13
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.5
7.0
224
1574
R02
ICPC
Shortness of breath/dyspnoea
1.7
7.0
136
847
B37.09
ICD-10 Finland
Unspecified candidal stomatitis
4.2
7.0
18
43
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
3.3
7.0
25
76
1CD02, ,
NOMESCO Finland
4.4
7.0
17
39
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.9
7.0
84
454
9732/3-C42.1
ICD-O-3
Plasma cell myeloma of bone marrow
5.9
6.9
18
31
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
2.6
6.9
38
148
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
13.9
6.9
11
8
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
13.9
6.9
11
8
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.9
6.9
86
470
SPAT1325
SPAT
Vaccination
1.4
6.9
336
2571
L02BG06
ATC
exemestane; oral
3.4
6.9
24
72
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.5
6.9
259
1886
SPAT1262
SPAT
Handing over of treatment supplies
1.6
6.8
183
1236
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
3.0
6.8
29
98
130
Kela drug reimbursment
Malignant tumour
1.8
6.8
100
575
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
4.1
6.8
18
44
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
3.8
6.8
20
53
J12.9
ICD-10 Finland
Viral pneumonia, unspecified
6.7
6.8
16
24
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
6.7
6.8
16
24
R2110
NOMESCO Finland
Giving the first information
2.1
6.8
65
323
J47
ICD-10 Finland
Bronchiectasis
3.1
6.8
28
93
N02BE01
ATC
paracetamol; systemic, rectal
1.6
6.8
939
8662
9673/3-C77.9
ICD-O-3
Mantle cell lymphoma of lymph node, NOS
40.3
6.8
8
*
WW402
NOMESCO Finland
Leucoferesis
40.3
6.8
8
*
ZX131
NOMESCO Finland
Intrathecal
40.3
6.8
8
*
GX1K5
NOMESCO Finland
Diffusion capacity
7.2
6.7
15
21
S18
ICPC
Laceration/cut
1.4
6.7
469
3823
B73
ICPC
Leukaemia
22.7
6.7
9
*
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
22.7
6.7
9
*
GX1E5
NOMESCO Finland
Flow volume spirometry and bronchodilation test
6.5
6.6
16
25
WX610
NOMESCO Finland
Patient controlled analgesia
6.5
6.6
16
25
B05DB
ATC
Hypertonic solutions
6.5
6.6
16
25
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
4.1
6.6
18
45
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
4.1
6.6
18
45
L04.0
ICD-10 Finland
Acute lymphadenitis of face, head and neck
4.2
6.6
17
41
WPB10
NOMESCO Finland
Making a convalescent care decision
8.8
6.6
13
15
L04AA24
ATC
abatacept; parenteral
10.1
6.5
12
12
K29.3
ICD-10 Finland
Chronic superficial gastritis
2.5
6.5
39
159
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
3.7
6.5
20
55
XCK10
NOMESCO Finland
Photography of fundus of eye
1.8
6.5
101
592
ED1AA
NOMESCO Finland
Mandibular X-ray examination
6.2
6.5
16
26
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
1.8
6.5
89
502
R4120
NOMESCO Finland
Occupational therapy
2.0
6.4
71
372
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
70.3
6.4
7
*
GD1BT
NOMESCO Finland
Biopsy of lung with X-ray guidance
14.4
6.4
10
7
A08.1
ICD-10 Finland
Acute gastroenteropathy due to Norovirus
14.4
6.4
10
7
WX721
NOMESCO Finland
Oxygen concentrator therapy
14.4
6.4
10
7
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
3.8
6.4
19
51
B01AB04
ATC
dalteparin; parenteral
2.2
6.4
53
250
H05BX01
ATC
cinacalcet; oral
6.6
6.3
15
23
D07AC01
ATC
betamethasone; topical
1.4
6.3
353
2759
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
8.2
6.3
13
16
284
Kela drug reimbursment
Nintedanib and pirfenidone
8.2
6.3
13
16
Z49.0
ICD-10 Finland
Preparatory care for dialysis
5.2
6.3
18
35
8140/3-C34.3
ICD-O-3
Adenocarcinoma, NOS, of lower lobe, lung
11.1
6.3
11
10
EE1AA
NOMESCO Finland
X-ray of upper jaw or palate
11.1
6.3
11
10
9680/3-C77.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph node, NOS
11.1
6.3
11
10
ZX100
NOMESCO Finland
Oral
3.4
6.3
22
66
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
3.4
6.3
22
66
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
2.9
6.3
29
103
TPX15
NOMESCO Finland
Removal of vascular injection port
9.3
6.3
12
13
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
6.3
425
3433
JN4ED
NOMESCO Finland
Body CT examination with specail preparation
18.1
6.3
9
5
120
Kela drug reimbursment
Hypogammaglobulinaemia
18.1
6.3
9
5
ZX070
NOMESCO Finland
Intensity modified radiotherapy
3.0
6.3
26
87
J17.3*B58.3
ICD-10 Finland
Pulmonary toxoplasmosis
+∞
6.3
6
*
1XX08, ,
NOMESCO Finland
+∞
6.3
6
*
08499
ICD-8 Finland
Malaria, Unspecified forms
+∞
6.3
6
*
9680/3-C71.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of brain, NOS
+∞
6.3
6
*
B53.0
ICD-10 Finland
Plasmodium ovale malaria
+∞
6.3
6
*
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.6
6.2
101
1623
WPA10
NOMESCO Finland
Proactive palliative care treatment plan
7.1
6.2
14
20
TGD00
NOMESCO Finland
Needle biopsy of lung
7.1
6.2
14
20
DHA10
NOMESCO Finland
Biopsy of cavity of nose
5.1
6.2
18
36
A49.8
ICD-10 Finland
Other bacterial infections of unspecified site
5.1
6.2
18
36
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
4.0
6.2
17
43
Z49.2
ICD-10 Finland
Other dialysis
5.8
6.2
16
28
A41.8
ICD-10 Finland
Other specified sepsis
3.0
6.1
26
88
B03XA03
ATC
methoxy polyethylene glycol-epoetin beta; parenteral
7.7
6.1
13
17
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
2.7
6.1
31
116
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
3.8
6.1
18
48
D47.1
ICD-10 Finland
Chronic myeloproliferative disease
12.6
6.1
10
8
NJ3DA
NOMESCO Finland
Long bones of extremities X-ray examination
6.7
6.0
14
21
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.6
6.0
130
833
N05BA04
ATC
oxazepam; oral
1.5
6.0
252
1868
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
270
178
19.84
320.56
2.8
1.7
—
—
—
0
0
337
329
14.39
319.80
3.3
2.8
—
—
—
0
0
247
137
23.02
318.16
2.1
1.5
—
—
—
0
0
251
151
21.30
311.26
2.2
1.5
—
—
—
0
0
281
137
27.30
307.65
2.0
1.6
—
—
—
0
0
330
236
19.63
307.65
2.8
1.7
—
—
—
0
0
316
175
25.03
307.65
2.1
1.6
—
—
—
0
0
329
241
19.13
307.65
2.7
1.7
—
—
—
0
0
308
201
20.97
307.65
7.1
6.4
395.39
372.93
iu/ml
0.06
66
29
419
89
75.90
307.65
1.8
1.7
—
—
—
0
0
234
142
20.72
288.27
2.4
1.6
—
—
—
0
0
229
161
17.74
261.16
2.6
1.7
—
—
—
0
0
229
161
17.74
261.16
2.6
1.7
—
—
—
0
0
157
42
43.51
258.85
1.3
1.5
—
—
—
0
0
136
26
59.63
241.43
1.3
1.2
—
—
—
0
0
237
209
14.22
236.58
1.9
1.5
—
—
—
0
0
209
156
16.34
229.82
3.8
3.2
977.65
2088.79
u/ml
0.31
17
14
188
115
19.55
229.23
2.5
1.7
—
—
—
0
0
180
110
19.41
219.34
2.3
1.6
—
—
—
0
0
180
110
19.41
219.34
2.3
1.6
—
—
—
0
0
138
58
27.10
196.79
2.6
2.1
—
—
—
0
0
142
71
22.85
188.91
3.7
2.8
35.72
42.44
%
1.57
81
38
446
1074
6.34
188.55
3.4
1.8
—
—
—
0
0
525
1503
5.81
182.00
3.9
1.9
—
—
—
0
0
433
1069
6.06
176.74
3.2
1.8
—
—
—
0
0
149
103
16.60
169.54
2.8
1.7
—
—
—
0
0
144
94
17.50
168.82
2.8
1.8
—
—
—
0
0
345
730
6.45
165.05
6.4
2.7
8.21
10.71
g/l
14.57
335
669
119
64
20.75
152.81
2.4
1.6
—
—
—
0
0
407
1069
5.48
152.08
10.6
4.3
261.86
251.66
u/l
0.51
396
1017
108
54
22.09
143.01
2.5
1.6
—
—
—
0
0
107
55
21.47
139.97
2.6
1.6
—
—
—
0
0
225
397
6.88
127.17
3.1
2.0
0.92
2.03
ug/l
0.78
210
357
77
21
39.38
124.97
2.3
1.7
—
—
—
0
0
112
83
14.93
121.92
2.6
1.7
—
—
—
0
0
101
63
17.57
120.47
3.4
2.1
507.76
589.66
e6/l
0.23
93
53
88
41
23.26
119.68
1.8
2.0
126999.06
63679.14
u/ml
—
18
7
114
90
14.03
119.61
1.4
1.3
—
—
—
0
0
255
588
5.36
107.51
2.8
1.8
1.02
1.45
g/l
2.92
227
545
106
89
13.09
106.97
2.9
1.6
—
—
—
0
0
106
89
13.09
106.97
2.9
1.6
—
—
—
0
0
106
89
13.09
106.97
2.9
1.6
—
—
—
0
0
389
1267
4.22
105.69
13.4
5.9
1.07
1.03
mmol/l
1.38
379
1173
435
1559
3.98
102.80
7.4
3.6
0.81
0.82
mmol/l
0.49
422
1458
205
405
6.00
102.25
2.6
1.5
8.43
11.68
u/ml
0.34
15
12
269
681
4.92
101.08
2.6
1.6
—
—
—
0
0
794
4286
4.15
100.23
18.4
6.1
2.29
2.88
%
13.44
774
4021
805
4404
4.17
99.18
18.7
6.2
26.05
27.57
%
2.33
786
4140
796
4333
4.11
98.53
17.2
6.0
59.14
57.24
%
3.13
779
4075
833
4716
4.26
96.35
18.6
6.3
0.16
0.19
e9/l
10.59
781
4158
55
15
38.56
88.89
1.2
1.3
—
—
—
0
0
328
1065
3.98
87.51
5.7
2.8
2.05
1.80
%
2.51
307
962
111
134
9.11
86.62
1.2
1.1
—
—
—
0
0
255
694
4.49
86.49
9.2
4.1
0.61
0.58
%
0.12
181
240
859
5299
3.94
79.71
31.2
9.4
4.21
4.13
e9/l
0.46
804
4639
119
179
7.34
76.92
1.5
1.4
89.60
105.61
u/ml
0.75
18
31
148
282
5.92
75.85
1.8
1.7
—
—
—
0
0
263
805
3.99
75.27
5.4
2.8
74.95
71.33
e9/l
0.63
197
631
46
14
34.26
71.93
1.8
2.2
—
—
—
0
0
180
427
4.85
71.82
2.5
2.1
1.49
1.50
g/l
0.03
153
375
699
3954
3.14
71.44
11.8
5.1
33.50
35.43
g/l
12.83
672
3705
117
195
6.60
68.51
1.3
1.2
—
—
—
0
0
64
49
13.81
67.85
1.5
1.2
—
—
—
0
0
85
100
9.13
67.42
3.4
4.8
—
—
—
0
0
785
4832
3.24
67.40
17.6
6.6
10.18
11.51
umol/l
2.78
766
4604
752
4590
3.06
64.08
19.5
7.2
1.20
1.21
mmol/l
2.21
636
3925
298
1095
3.37
63.64
10.8
8.7
4.81
5.11
kpa
6.85
283
1051
298
1095
3.37
63.64
10.8
8.7
10.83
12.18
kpa
5.09
282
1055
125
242
5.71
62.67
2.4
1.7
—
—
—
0
0
109
186
6.40
62.25
1.3
1.3
268.46
263.19
u/ml
0.05
74
113
707
4222
2.92
61.80
16.3
6.4
1.20
1.21
mmol/l
2.06
679
3849
74
84
9.38
60.25
1.8
1.1
—
—
u/ml
—
0
0
292
1092
3.29
60.24
10.8
8.7
1.08
1.15
mmol/l
0.11
233
870
422
1987
2.83
57.29
4.3
2.5
4.45
5.53
e6/l
0.91
404
1801
315
1270
3.08
56.78
4.0
2.5
22.08
23.30
%
0.86
276
1091
245
852
3.42
56.56
17.4
7.6
11.46
9.46
mmol/l
4.01
238
812
599
3391
2.70
56.19
5.7
3.3
—
—
—
0
0
533
2848
2.71
56.18
5.6
3.2
49.07
88.86
e6/l
0.61
464
2218
59
54
11.49
55.90
5.9
3.1
—
—
—
0
0
47
29
16.89
55.84
3.9
2.0
—
—
—
0
0
91
144
6.80
55.81
7.6
3.6
1.45
1.17
%
0.33
85
133
343
1465
2.96
55.61
3.6
2.1
29.19
29.78
s
1.17
338
1417
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
132
304
4.80
54.07
3.7
2.6
0.39
0.34
u/ml
0.70
87
181
341
1472
2.92
54.00
3.9
2.4
11.77
13.30
umol/l
4.03
323
1373
230
791
3.42
53.85
6.0
2.9
63.34
66.57
g/l
5.89
221
721
322
1353
2.96
53.52
3.9
2.4
2.16
2.31
g/l
4.89
303
1260
102
191
5.79
52.81
3.5
2.7
15.04
16.03
%
1.23
61
103
244
891
3.24
51.63
9.0
3.5
1.90
1.87
mmol/l
0.04
211
729
492
2616
2.61
51.12
5.6
3.1
0.28
0.49
e6/l
2.85
426
2007
132
325
4.48
49.64
2.0
1.6
600.00
180.00
titre
—
5
11
233
857
3.19
48.47
3.3
2.2
357.81
371.69
nmol/l
0.32
223
800
252
983
3.03
47.24
11.3
9.2
94.53
95.70
%
1.80
242
953
52
51
10.66
46.95
3.7
1.8
—
—
—
0
0
52
51
10.66
46.95
3.7
1.8
—
—
—
0
0
55
60
9.60
46.01
1.4
1.3
—
—
—
0
0
460
2461
2.50
46.01
7.2
2.8
2856.20
6742.24
umol/l
1.48
427
2154
46
40
11.96
44.95
4.1
2.0
—
—
—
0
0
46
40
11.96
44.95
4.1
2.0
—
—
—
0
0
676
4349
2.46
44.32
17.7
15.0
1.20
1.25
inr
0.87
223
1254
46
41
11.67
44.24
4.1
1.9
—
—
—
0
0
115
281
4.46
43.53
1.5
1.5
0.55
0.08
iu/ml
0.54
24
50
158
491
3.59
42.77
10.7
11.3
24.32
24.45
mmol/l
0.21
153
480
44
39
11.71
42.45
35.0
36.4
106.76
128.88
ug/l
0.93
37
33
113
281
4.37
41.78
1.9
1.2
—
—
—
0
0
350
1744
2.48
39.73
2.6
1.5
2.21
2.49
g/l
1.18
259
1054
86
180
5.10
39.20
7.0
3.7
57.76
58.17
%
0.08
86
180
164
551
3.33
39.14
1.8
1.5
—
—
—
0
0
922
7073
2.98
38.67
23.7
7.8
81.51
78.58
u/l
1.06
903
6664
225
917
2.83
38.26
12.8
9.6
114.88
121.12
g/l
3.95
218
898
105
264
4.29
38.20
6.0
3.6
1.92
1.56
mg/l
3.13
99
244
769
5442
2.41
37.73
11.5
5.1
6.75
6.72
mmol/l
0.14
749
5113
88
195
4.82
37.50
1.8
1.3
—
—
—
0
0
88
195
4.82
37.50
1.8
1.3
—
—
—
0
0
513
3116
2.22
35.83
8.6
3.6
2.33
2.35
mmol/l
2.79
485
2737
110
301
3.95
35.65
8.0
3.9
59.72
72.92
mg/l
0.24
86
246
105
279
4.06
35.43
2.0
1.4
0.23
0.23
g/l
0.09
98
265
33
25
13.58
34.94
1.1
1.1
—
—
—
0
0
108
296
3.94
34.91
7.9
3.8
17.87
1.82
ratio
—
8
26
372
1997
2.31
34.90
2.3
1.7
1.78
1.24
mg/l
0.96
317
1539
109
302
3.90
34.69
8.1
3.9
53.48
43.49
mg/l
0.37
86
249
189
737
2.89
34.66
9.8
3.7
1.22
1.23
mmol/l
0.75
180
639
170
626
3.03
34.56
5.5
3.8
4.92
5.14
kpa
2.72
165
599
40
42
9.85
34.32
4.1
4.1
—
—
—
0
0
106
291
3.93
34.17
2.0
1.4
1.13
1.16
g/l
0.47
101
276
38
38
10.33
33.75
1.3
1.1
—
—
—
0
0
84
196
4.56
33.56
8.4
4.6
2.49
2.62
mmol/l
0.16
68
134
804
5963
2.33
32.83
6.8
4.4
1323.83
2349.11
e6/l
0.27
12
96
161
593
3.01
32.63
5.6
3.8
1.87
1.77
mmol/l
0.12
119
449
123
387
3.46
32.37
2.2
2.0
41.71
38.87
u/l
0.59
111
345
233
1060
2.52
31.27
5.5
2.8
6.87
8.56
umol/l
0.81
208
935
411
2396
2.15
30.66
8.3
3.9
89.65
89.78
%
0.04
395
2349
83
206
4.28
30.62
3.4
2.3
120.03
128.55
g/l
1.91
64
151
482
2991
2.10
30.45
6.6
3.3
34.01
33.45
u/l
0.08
464
2853
64
130
5.17
30.12
6.1
6.5
11.73
11.05
mg/l
0.48
59
119
45
67
6.96
29.05
1.1
1.2
—
—
—
0
0
636
4435
2.04
28.51
7.4
4.9
0.00
0.00
estimate
-0.00
169
849
636
4449
2.03
28.09
5.6
3.6
0.00
0.00
estimate
0.50
178
894
640
4489
2.03
28.03
5.6
3.6
0.00
0.00
estimate
0.50
163
808
460
2884
2.03
27.50
3.6
2.6
63.87
59.32
u/l
0.46
434
2677
86
240
3.80
27.00
2.0
2.2
11.48
11.97
mg/l
0.19
79
220
390
2319
2.06
26.85
2.8
2.2
3.25
3.04
mg/l
0.96
353
1964
39
55
7.32
26.41
12.2
7.1
51.60
71.56
u/ml
0.27
15
16
109
364
3.22
25.94
6.0
2.6
3.41
3.58
g/l
0.58
103
330
109
364
3.22
25.94
6.0
2.6
—
—
—
0
0
109
364
3.22
25.94
6.0
2.6
7.54
7.29
g/l
0.73
103
330
152
613
2.72
25.77
12.6
8.1
24.56
24.55
mmol/l
0.01
143
588
438
2748
1.99
25.69
4.5
3.0
1930.26
1314.65
ng/l
1.66
402
2347
850
6743
2.19
25.08
9.3
4.1
19.24
12.11
mm/h
19.93
826
6221
197
912
2.42
25.03
2.5
2.3
0.22
0.21
g/l
0.89
179
862
204
968
2.36
24.48
5.7
3.3
—
—
—
0
0
102
339
3.22
24.44
5.8
2.7
9.10
10.44
g/l
1.22
95
304
132
508
2.82
24.43
17.2
12.3
—
—
—
0
0
312
1759
2.08
24.41
5.0
3.9
237.02
359.25
ng/l
0.68
266
1398
172
768
2.47
23.57
3.6
2.9
184.59
202.00
ng/l
0.25
158
697
90
284
3.36
23.45
2.2
1.8
—
—
—
0
0
291
1621
2.09
23.37
4.4
2.8
0.94
1.03
e6/l
0.19
187
937
50
103
5.04
23.14
4.3
2.7
—
—
—
0
0
36
55
6.74
22.67
3.3
1.7
—
—
—
0
0
36
55
6.74
22.67
3.3
1.7
—
—
—
0
0
99
341
3.09
22.31
6.4
2.7
3.19
2.99
g/l
0.98
93
307
184
871
2.34
22.05
3.4
2.4
36.81
33.92
u/l
0.37
161
754
75
224
3.52
21.27
1.2
1.3
—
—
—
0
0
53
126
4.37
20.64
4.2
2.3
32.72
32.61
pg
0.06
53
126
269
1518
2.03
20.51
4.8
3.0
1.48
1.87
e6/l
0.66
167
836
42
84
5.16
20.10
9.7
3.6
58.28
54.00
%
0.53
37
75
294
1723
1.97
20.07
4.8
3.2
2.46
2.45
mmol/l
0.59
270
1515
104
393
2.82
19.83
11.1
6.4
1.75
1.61
%
0.56
99
372
133
569
2.52
19.83
2.4
1.6
—
—
—
0
0
129
544
2.56
19.82
1.9
1.2
168.99
255.85
u/ml
0.77
114
497
538
3836
1.80
19.58
4.5
2.7
285.52
140.12
ug/l
2.97
509
3527
590
4343
1.78
19.08
5.2
2.6
—
—
—
0
0
705
5470
1.82
19.06
3.6
2.9
—
—
—
0
0
89
317
2.97
18.89
4.9
2.8
0.95
1.32
g/l
0.40
79
279
155
726
2.32
18.88
6.1
3.8
108.12
84.73
ng/l
2.06
144
641
71
225
3.31
18.35
1.1
1.1
—
—
—
0
0
516
3683
1.76
18.29
3.2
2.3
77.40
77.37
nmol/l
0.01
490
3277
100
388
2.74
18.11
11.6
6.5
0.95
0.90
%
0.32
95
369
77
264
3.06
17.46
1.5
1.3
—
—
—
0
0
26
37
7.17
17.43
2.1
2.4
54.38
64.16
ug/l
0.25
26
37
347
2242
1.80
17.03
1.8
1.5
18.80
20.56
nmol/l
1.48
314
1894
25
15
17.03
16.12
1.4
1.0
—
—
—
0
0
63
201
3.27
16.11
1.8
1.6
—
—
—
0
0
490
3536
1.70
16.02
5.5
3.7
32.28
53.29
ng/l
1.18
392
2531
103
435
2.51
15.71
8.4
3.6
51.04
49.60
%
0.21
103
429
910
7849
1.97
15.32
52.8
17.6
15.09
15.01
%
0.22
904
7725
38
88
4.44
15.31
1.4
1.3
—
—
—
0
0
78
296
2.76
14.73
5.0
2.5
35.26
37.87
g/l
2.67
72
262
176
955
2.01
14.55
5.1
4.5
15.40
27.86
ug/l
0.43
143
798
403
2815
1.69
14.50
3.1
2.2
115.49
249.29
u/l
3.34
384
2655
25
21
12.16
14.12
2.0
1.3
—
—
—
0
0
1003
9045
2.38
13.85
49.4
14.8
25.77
24.73
mg/l
0.54
912
7189
86
356
2.54
13.66
5.8
4.3
1.50
1.39
mmol/l
0.43
81
349
60
206
3.02
13.59
1.6
1.3
4.50
51.96
e6/l
0.99
50
164
60
206
3.02
13.59
1.7
1.3
168.27
717.45
e6/l
0.51
55
168
52
164
3.28
13.56
1.3
1.1
—
—
—
0
0
44
125
3.63
13.47
1.1
1.1
—
—
—
0
0
336
2276
1.69
13.35
4.5
2.4
—
—
—
0
0
142
749
2.03
12.63
3.3
2.7
54.87
65.47
ml/min/173m2
1.89
55
304
58
209
2.87
12.07
2.1
1.4
—
—
—
0
0
30
71
4.32
11.79
1.5
1.2
90.00
89.23
titre
—
6
13
20
17
11.96
11.35
1.6
2.1
—
—
—
0
0
452
3400
1.56
11.27
5.9
3.8
—
—
—
0
0
342
2412
1.61
11.23
6.2
3.9
0.00
0.00
estimate
0.69
148
816
38
111
3.51
11.19
1.3
1.3
—
—
—
0
0
38
114
3.42
10.75
1.2
1.1
—
—
—
0
0
254
1686
1.66
10.55
1.8
1.7
1200.77
1187.88
nmol/l
0.07
208
1271
25
56
4.55
10.52
3.4
1.7
—
—
—
0
0
43
144
3.07
10.20
1.4
1.2
1.50
3.93
u/ml
0.73
14
41
67
284
2.45
10.15
2.1
1.7
—
—
—
0
0
66
278
2.46
10.13
1.4
1.1
—
—
—
0
0
32
90
3.63
9.98
6.0
2.2
—
—
—
0
0
17
15
11.49
9.58
4.5
6.3
—
—
—
0
0
19
22
8.77
9.31
1.5
1.4
—
—
—
0
0
64
277
2.39
9.28
1.4
1.1
—
—
—
0
0
231
1559
1.61
8.82
1.3
1.3
60.50
32.59
iu/ml
1.56
83
496
16
15
10.81
8.80
1.9
1.0
—
—
—
0
0
55
228
2.49
8.76
1.5
1.2
7.58
2.47
u/ml
—
6
23
22
52
4.30
8.68
2.5
1.3
—
—
—
0
0
15
13
11.68
8.58
1.5
1.2
—
—
—
0
0
41
149
2.82
8.46
1.2
1.3
—
—
—
0
0
55
232
2.44
8.45
1.5
1.2
4.82
10.35
u/ml
—
10
35
18
23
7.94
8.38
1.1
1.1
—
—
—
0
0
40
147
2.79
8.10
1.4
1.2
5.07
6.85
u/ml
0.29
14
68
474
3789
1.44
7.94
2.3
2.0
92.49
94.72
pmol/l
0.49
297
1976
21
52
4.10
7.82
1.0
1.0
—
—
—
0
0
21
52
4.10
7.82
2.6
1.3
—
—
—
0
0
73
360
2.10
7.77
5.3
2.0
—
—
—
0
0
30
97
3.15
7.60
2.5
2.3
—
—
—
0
0
134
816
1.73
7.53
2.4
2.5
8.04
7.50
ug/l
0.12
121
729
215
1477
1.57
7.51
1.3
1.3
33.67
11.52
u/ml
1.54
60
559
45
184
2.51
7.41
1.6
1.2
27.46
28.12
u/ml
0.01
11
13
24
69
3.53
7.29
1.5
1.1
6.44
0.97
u/ml
0.72
13
37
26
79
3.35
7.27
1.2
1.4
—
—
—
0
0
53
237
2.30
7.19
1.7
1.4
13.59
9.36
u/l
0.98
42
182
161
1047
1.63
7.05
3.0
2.5
194.74
138.30
ug/g
0.77
127
840
37
142
2.66
6.93
1.1
1.1
—
13.94
—
0
7
57
267
2.20
6.93
1.6
1.4
241.12
288.93
ug/g
1.00
34
156
31
110
2.87
6.73
1.7
1.3
2369.08
1638.12
e6/l
0.37
24
73
82
448
1.90
6.58
1.5
1.3
—
—
—
0
0
52
240
2.23
6.57
1.4
1.3
—
—
—
0
0
688
5999
1.40
6.45
4.6
3.2
69.70
52.24
u/l
3.17
652
5582
17
31
5.55
6.31
2.1
1.4
—
—
—
0
0
1001
9420
1.78
6.29
48.6
17.3
4.01
3.98
mmol/l
4.43
993
9165
9
5
18.13
6.27
3.4
3.0
—
—
—
0
0
50
232
2.21
6.25
2.9
3.2
31.98
34.48
umol/l
0.40
44
209
25
83
3.06
6.10
1.6
1.3
39.41
32.05
%
0.39
17
58
63
327
1.98
5.89
3.0
1.8
—
—
—
0
0
14
22
6.43
5.87
4.7
1.2
—
—
—
0
0
10
9
11.20
5.80
1.4
1.1
—
—
—
0
0
996
9396
1.70
5.71
48.0
17.1
138.93
139.64
mmol/l
14.07
990
9160
27
98
2.80
5.66
1.8
1.3
11531.94
103920.74
e6/l
0.76
17
53
1020
9692
1.83
5.63
29.2
10.8
26.79
26.96
u/l
0.12
1006
9351
86
504
1.77
5.54
2.6
3.4
4.00
4.57
pmol/l
4.62
74
435
17
47
3.66
5.49
3.4
2.4
91.35
102.85
%
0.52
17
47
24
83
2.93
5.48
1.1
1.0
—
—
—
0
0
20
62
3.27
5.46
1.4
1.6
5.74
6.17
u/l
0.15
14
50
16
43
3.76
5.38
2.8
1.3
—
—
—
0
0
16
43
3.76
5.38
2.8
1.3
—
—
—
0
0
46
220
2.14
5.37
1.2
1.3
223.14
239.44
miu/ml
0.08
11
101
31
125
2.52
5.32
2.6
1.5
—
—
—
0
0
52
262
2.03
5.30
1.7
1.4
—
—
—
0
0
16
45
3.59
5.06
1.2
1.1
1.11
1.06
ratio
—
8
14
30
123
2.48
4.99
2.7
1.5
—
—
—
0
0
197
1440
1.45
4.99
1.5
1.5
—
—
—
0
0
30
125
2.44
4.83
2.7
1.5
—
—
—
0
0
18
57
3.19
4.78
1.2
1.2
—
—
—
0
0
18
59
3.09
4.53
1.0
1.0
—
—
—
0
0
8
8
10.06
4.52
1.1
1.3
—
—
—
0
0
41
202
2.07
4.48
3.5
2.2
4260.43
4280.60
u/l
0.00
16
84
23
88
2.65
4.41
1.0
1.1
—
—
—
0
0
97
626
1.60
4.40
2.2
2.5
18.50
22.98
au/ml
—
5
41
7
6
11.73
4.28
2.4
2.0
1.14
1.75
%
—
7
6
64
373
1.76
4.25
4.4
3.6
489.34
3850.23
u/ml
0.67
54
320
25
104
2.44
4.08
1.1
1.1
103.04
96.27
%
0.58
25
98
8
10
8.05
4.06
1.1
1.3
—
—
—
0
0
28
123
2.31
4.06
2.7
1.5
—
—
—
0
0
28
123
2.31
4.06
2.7
1.5
—
—
—
0
0
28
124
2.29
3.99
2.7
1.5
—
—
—
0
0
21
81
2.62
3.99
1.0
1.0
—
—
—
0
0
23
94
2.48
3.90
1.0
1.1
—
—
—
0
0
14
38
3.72
3.80
7.1
2.9
237.71
205.29
u/l
0.46
14
38
14
44
3.21
3.78
1.4
1.4
—
—
—
0
0
25
109
2.32
3.70
1.9
1.6
52.40
59.93
%
0.37
15
72
30
142
2.14
3.67
1.1
1.1
—
—
—
0
0
9
16
5.66
3.66
1.3
1.4
—
—
—
0
0
14
40
3.53
3.61
2.0
1.3
51.42
58.73
%
0.32
14
30
15
51
2.97
3.58
1.2
1.1
—
—
—
0
0
11
26
4.26
3.51
1.6
1.2
—
—
—
0
0
8
13
6.19
3.50
11.0
8.4
5.30
6.22
mmol/l
—
8
13
6
6
10.05
3.50
2.7
5.5
—
—
—
0
0
18
70
2.60
3.39
1.3
1.1
—
—
—
0
0
18
70
2.60
3.39
1.3
1.1
—
—
—
0
0
19
76
2.53
3.39
3.2
4.7
73.44
46.36
u/ml
—
5
23
13
38
3.45
3.31
1.1
1.3
—
—
—
0
0
18
71
2.56
3.30
1.3
1.1
—
—
—
0
0
18
71
2.56
3.30
1.3
1.1
—
—
—
0
0
18
71
2.56
3.30
1.3
1.1
—
—
—
0
0
11
28
3.96
3.29
1.4
1.2
2.22
3.42
mmol/l
1.18
11
23
739
6804
1.27
3.29
4.5
3.9
14.80
14.84
pmol/l
0.16
682
6151
79
1156
0.66
3.21
4.1
4.6
29.61
32.08
%
1.50
62
773
41
234
1.78
3.00
2.0
1.7
6051.33
14127.87
e6/l
1.58
30
173
35
190
1.87
3.00
2.9
3.0
0.90
0.85
nmol/l
0.24
28
148
238
1938
1.29
2.97
1.2
1.3
0.81
1.64
u/ml
1.88
48
520
12
37
3.27
2.94
2.1
1.3
4.75
3.90
%
0.09
12
29
348
2977
1.25
2.88
4.8
3.2
6.97
7.67
mmol/l
2.10
310
2510
5
6
8.36
2.75
1.0
1.0
—
—
—
0
0
13
48
2.73
2.72
1.1
1.3
—
51.43
—
0
7
1035
10065
1.57
2.71
63.3
21.8
38.16
40.25
%
23.87
975
9412
10
29
3.47
2.69
1.0
1.1
—
—
—
0
0
10
29
3.47
2.69
1.0
1.1
—
—
—
0
0
1035
10067
1.57
2.68
62.5
21.7
7.27
6.75
e9/l
4.12
1024
9787
238
1965
1.27
2.65
5.6
4.0
1.02
1.02
kg/l
0.09
34
264
11
35
3.16
2.65
2.1
1.1
17.73
30.43
%
0.70
11
29
1035
10070
1.56
2.64
62.5
21.7
4.21
4.50
e12/l
43.09
1026
9792
12
41
2.95
2.62
1.0
1.0
—
—
—
0
0
906
8633
1.29
2.60
38.2
13.7
76.98
80.67
ml/min/173m2
4.52
824
7134
327
2807
1.24
2.58
5.4
3.3
1484.46
289.37
mg/l
1.97
240
1811
1034
10065
1.54
2.55
62.7
21.7
235.77
247.99
e9/l
5.53
1025
9814
6
11
5.48
2.54
1.0
1.0
—
—
—
0
0
51
326
1.59
2.50
1.6
1.4
37.00
29.16
iu/l
0.63
41
275
15
63
2.40
2.47
1.2
1.7
—
—
—
0
0
234
1944
1.26
2.46
1.7
1.7
52217202.92
27233407.41
pmol/l
0.19
203
1601
13
52
2.52
2.36
1.1
1.4
—
275.00
—
0
6
12
46
2.63
2.36
1.4
1.1
1.30
1.09
u/l
—
7
25
7
17
4.14
2.36
1.0
1.1
105.29
96.29
%
—
7
17
11
39
2.84
2.34
4.5
2.3
22.72
236.38
ug/l
0.47
11
32
11
39
2.84
2.34
1.3
1.1
—
—
—
0
0
18
86
2.11
2.23
1.3
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
13
54
2.42
2.20
1.2
1.1
—
—
—
0
0
6
14
4.30
2.15
1.0
1.1
—
—
—
0
0
7
19
3.70
2.15
2.4
1.2
—
—
—
0
0
7
19
3.70
2.15
1.0
1.2
—
—
—
0
0
51
741
0.67
2.06
1.5
1.8
—
—
—
0
0
9
32
2.83
2.00
1.4
1.1
—
—
—
0
0
288
2511
1.20
1.88
1.7
1.7
1.51
1.38
mmol/l
1.58
244
2089
334
2957
1.19
1.84
5.4
3.9
16.53
8.89
mg/mmol
1.89
236
1877
14
66
2.14
1.82
1.7
1.2
—
—
—
0
0
14
66
2.14
1.82
1.7
1.2
—
—
—
0
0
16
81
1.99
1.75
2.6
1.9
0.67
2.16
u/field
—
9
38
8
30
2.68
1.72
1.5
1.1
—
—
—
0
0
5
13
3.86
1.71
13.6
6.3
—
—
—
0
0
8
31
2.59
1.66
1.0
1.1
—
—
—
0
0
39
261
1.51
1.65
1.4
1.5
238.33
291.53
mu/l
0.88
34
241
5
14
3.58
1.61
2.8
1.5
—
—
—
0
0
861
8275
1.19
1.60
5.3
4.6
2.09
2.09
mu/l
0.00
793
7537
6
20
3.01
1.58
1.7
1.2
0.36
0.33
ug/l
—
6
13
12
57
2.12
1.55
1.2
1.1
—
—
—
0
0
9
39
2.32
1.43
1.2
1.2
—
21.33
u/ml
—
0
6
5
123
0.40
1.37
1.6
1.6
—
—
—
0
0
11
54
2.05
1.33
1.1
1.4
—
—
—
0
0
13
69
1.89
1.29
2.5
2.0
19.26
19.37
nmol/l
0.01
13
63
92
746
1.25
1.25
2.4
2.2
11.56
12.81
nmol/l
0.69
80
662
8
36
2.23
1.24
1.0
1.1
103.50
100.90
%
—
8
31
13
70
1.87
1.24
1.1
1.1
—
70.43
—
0
7
7
30
2.34
1.12
1.0
1.2
—
—
—
0
0
7
30
2.34
1.12
1.0
1.1
—
—
—
0
0
130
1112
1.19
1.08
1.8
1.8
1.62
1.51
%
0.67
108
965
56
437
1.30
1.06
1.0
1.0
—
—
—
0
0
12
67
1.80
1.05
2.8
1.6
1.02
0.99
g/l
0.14
12
67
7
36
1.95
0.97
8.3
2.0
—
—
—
0
0
41
314
1.32
0.91
1.8
1.9
—
—
—
0
0
6
30
2.01
0.87
1.0
1.2
—
—
—
0
0
71
593
1.21
0.80
1.3
1.2
105.28
147.91
iu/ml
0.49
21
233
21
148
1.43
0.78
1.6
1.6
—
—
—
0
0
183
2020
0.89
0.77
2.3
3.1
0.67
0.75
ug/l
0.64
126
1343
11
174
0.63
0.77
1.5
1.5
—
—
—
0
0
18
256
0.70
0.76
1.6
1.6
—
—
—
0
0
49
397
1.25
0.74
1.9
1.9
—
—
—
0
0
12
76
1.59
0.72
4.3
2.4
6.40
7.29
umol/l
—
7
54
9
57
1.58
0.71
1.4
1.4
131.33
161.89
pmol/l
—
9
57
904
9205
0.89
0.69
5.2
5.0
2.66
2.73
mmol/l
1.64
831
8468
257
2766
0.91
0.69
3.8
4.3
22.67
20.99
%
0.85
125
1336
5
27
1.86
0.68
1.2
1.1
40.48
30.58
nmol/l
—
5
22
7
42
1.67
0.68
2.0
2.6
47357.14
40869.17
ug/l
—
7
42
16
111
1.45
0.66
2.3
2.4
32.60
21.88
mg/l
—
5
30
5
30
1.67
0.61
1.0
1.2
10.20
8.87
ug/l
—
5
30
8
123
0.65
0.55
1.0
1.0
—
—
—
0
0
83
738
1.13
0.49
1.7
1.9
—
—
—
0
0
7
45
1.56
0.49
1.3
1.1
—
—
—
0
0
31
253
1.23
0.48
2.2
2.4
187.80
93.93
ug/min
0.73
22
149
6
92
0.65
0.42
1.7
1.6
—
—
—
0
0
0
15
0.00
0.41
0.0
2.6
—
—
—
0
0
7
102
0.68
0.39
1.7
1.4
—
—
—
0
0
13
99
1.32
0.35
1.3
1.3
41.47
29.09
u/l
0.66
13
85
357
3442
1.06
0.35
4.4
5.0
2.84
2.49
ug/l
0.33
321
3069
7
53
1.32
0.31
1.1
1.5
1.56
1.52
g/l
—
7
53
12
152
0.79
0.29
1.5
1.6
—
—
—
0
0
19
227
0.83
0.28
1.5
1.4
—
—
—
0
0
5
71
0.70
0.26
1.2
1.5
1.06
1.31
promille
—
5
58
11
138
0.80
0.25
1.5
1.5
—
—
—
0
0
11
138
0.80
0.25
1.5
1.5
—
—
—
0
0
11
137
0.80
0.24
1.5
1.5
—
—
—
0
0
11
137
0.80
0.24
1.5
1.5
—
—
—
0
0
890
8978
0.95
0.23
4.7
4.5
1.40
1.45
mmol/l
2.23
817
8250
7
92
0.76
0.22
1.3
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
3.0
—
72.23
—
0
11
874
8666
1.04
0.21
4.5
4.0
1.37
1.31
mmol/l
1.86
797
7923
0
13
0.00
0.21
0.0
2.4
—
0.54
—
0
13
0
14
0.00
0.20
0.0
2.7
—
—
—
0
0
22
193
1.14
0.19
6.0
3.7
35.75
22.32
mg/l
0.76
16
122
32
289
1.11
0.19
1.6
1.7
—
—
—
0
0
5
67
0.75
0.17
1.8
1.4
86.00
78.25
umol/l
—
5
67
111
1157
0.95
0.16
20.2
7.3
—
—
—
0
0
898
9036
0.96
0.16
4.8
4.5
4.55
4.62
mmol/l
1.33
834
8366
29
266
1.09
0.14
1.6
1.7
46.24
40.47
nmol/l
0.52
29
256
9
106
0.85
0.13
1.7
1.7
—
—
—
0
0
86
825
1.05
0.13
2.0
2.0
—
—
—
0
0
122
1182
1.04
0.12
1.5
1.4
—
—
—
0
0
891
8875
1.02
0.08
5.2
4.7
5.99
5.98
mmol/l
0.03
823
8071
13
143
0.91
0.07
1.7
1.7
—
—
—
0
0
25
241
1.04
0.02
1.3
1.4
—
—
—
0
0
849
8476
1.01
0.02
6.5
5.9
39.78
39.99
mmol/mol
0.29
802
7832
5
52
0.96
-0.00
2.0
2.5
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
5.2
—
392.60
—
0
5
9
92
0.98
-0.00
1.1
1.2
1.30
1.43
nmol/l
—
9
83
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.3
—
24.50
—
0
6
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint AB1_PROTOZOAL and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| AB1_PROTOZOAL | 3.997 [3.21, 4.98] | < 0.001 |
| Birth year | 0.994 [0.99, 1.0] | 0.171 |
During the follow-up period (1.1.1998 — 31.12.2019), 470 out of 1914 females with AB1_PROTOZOAL died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| AB1_PROTOZOAL | 3.555 [2.88, 4.38] | < 0.001 |
| Birth year | 0.981 [0.97, 0.99] | < 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 575 out of 2159 males with AB1_PROTOZOAL died.
Mortality risk
Mortality risk for people of age
years, who have AB1_PROTOZOAL.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.377% | 0.561% |
| 5 | 2.125% | 3.161% |
| 10 | 5.209% | 8.234% |
| 15 | 9.94% | 14.814% |
| 20 | 17.521% | 24.247% |
Relationships between endpoints
↥Index endpoint: AB1_PROTOZOAL – Protozoal diseases
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data